234 related articles for article (PubMed ID: 31981559)
1. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study.
Kuhn L; Saidu R; Boa R; Tergas A; Moodley J; Persing D; Campbell S; Tsai WY; Wright TC; Denny L
Lancet Glob Health; 2020 Feb; 8(2):e296-e304. PubMed ID: 31981559
[TBL] [Abstract][Full Text] [Related]
2. Performance of Xpert HPV on Self-collected Vaginal Samples for Cervical Cancer Screening Among Women in South Africa.
Saidu R; Kuhn L; Tergas A; Boa R; Moodley J; Svanholm-Barrie C; Persing D; Campbell S; Tsai WY; Wright TC; Denny L
J Low Genit Tract Dis; 2021 Jan; 25(1):15-21. PubMed ID: 33105451
[TBL] [Abstract][Full Text] [Related]
3. Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women.
Johnson LG; Saidu R; Mbulawa Z; Williamson AL; Boa R; Tergas A; Moodley J; Persing D; Campbell S; Tsai WY; Wright TC; Denny L; Kuhn L
Cancer Med; 2020 Sep; 9(18):6813-6824. PubMed ID: 32706163
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Reflex Testing with Cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening.
Johnson LG; Saidu R; Svanholm-Barrie C; Boa R; Moodley J; Tergas A; Persing D; Campbell SA; Tsai WY; Wright TC; Denny L; Kuhn L
Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):595-603. PubMed ID: 35027434
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
Kuhn L; Wang C; Tsai WY; Wright TC; Denny L
AIDS; 2010 Oct; 24(16):2553-61. PubMed ID: 20706107
[TBL] [Abstract][Full Text] [Related]
7. Phase I of the DiaVACCS screening trial: Study design, methods, population demographics and baseline results.
Dreyer G; Snyman LC; Van der Merwe FH; Richter KL; Dreyer GJ; Visser C; Botha MH
S Afr Med J; 2022 Jul; 112(7):478-486. PubMed ID: 36217858
[TBL] [Abstract][Full Text] [Related]
8. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach.
Kunckler M; Schumacher F; Kenfack B; Catarino R; Viviano M; Tincho E; Tebeu PM; Temogne L; Vassilakos P; Petignat P
Cancer Med; 2017 Jul; 6(7):1752-1761. PubMed ID: 28580596
[TBL] [Abstract][Full Text] [Related]
10. Utility of Extended HPV Genotyping as Primary Cervical Screen in an Unscreened Population With High HIV Co-Infection Rate.
Botha MH; Van der Merwe FH; Snyman LC; Dreyer GJ; Visser C; Dreyer G
J Low Genit Tract Dis; 2023 Jul; 27(3):212-216. PubMed ID: 37097217
[TBL] [Abstract][Full Text] [Related]
11. Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa.
Denny L; Saidu R; Boa R; Mbatani N; Castor D; Moodley J; Kuhn L
Sci Rep; 2023 Sep; 13(1):16182. PubMed ID: 37758811
[TBL] [Abstract][Full Text] [Related]
12. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
[TBL] [Abstract][Full Text] [Related]
13. Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus.
Vink FJ; Meijer CJLM; Lissenberg-Witte BI; Visser C; Duin S; Snyman LC; Richter KL; van der Merwe FH; Botha MH; Steenbergen RDM; Dreyer G
Clin Infect Dis; 2023 Feb; 76(3):416-423. PubMed ID: 36366827
[TBL] [Abstract][Full Text] [Related]
14. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa.
Firnhaber C; Mayisela N; Mao L; Williams S; Swarts A; Faesen M; Levin S; Michelow P; Omar T; Hudgens MG; Williamson AL; Allan B; Lewis DA; Smith JS
PLoS One; 2013; 8(1):e53494. PubMed ID: 23326441
[TBL] [Abstract][Full Text] [Related]
15. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV.
Kahesa C; Thomsen LT; Linde DS; Mchome B; Katanga J; Swai P; Manongi R; Kjaerem M; Iftner T; Waldstrøm M; Mwaiselage J; Rasch V; Kjaer SK
Int J Cancer; 2023 Feb; 152(4):686-696. PubMed ID: 36093587
[TBL] [Abstract][Full Text] [Related]
16. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
[TBL] [Abstract][Full Text] [Related]
17. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.
Zhao FH; Lin MJ; Chen F; Hu SY; Zhang R; Belinson JL; Sellors JW; Franceschi S; Qiao YL; Castle PE;
Lancet Oncol; 2010 Dec; 11(12):1160-71. PubMed ID: 21075054
[TBL] [Abstract][Full Text] [Related]
18. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
19. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
20. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
